IJDVL Close
 

Figure 2: The patient after 24 weeks of vismodegib therapy: Absence of diagnostic clinical manifestations of basal cell carcinoma

Figure 2: The patient after 24 weeks of vismodegib therapy: Absence of diagnostic clinical manifestations of basal cell carcinoma